Discontinuation report HEPARIN SODIUM INJECTION USP
| Report ID | 1448 |
| Drug Identification Number | 02382296 |
| Brand name | HEPARIN SODIUM INJECTION USP |
| Common or Proper name | HEPARIN |
| Company Name | PFIZER CANADA ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | HEPARIN SODIUM |
| Strength(s) | 1000UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS SUBCUTANEOUS |
| Packaging size | 25 x 10ML |
| ATC code | B01AB |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for discontinuation | Other (Please describe in comments) |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2017-04-01 |
| Remaining supply date | 2017-04-01 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | Discontunation of product / Discontinuité du produit |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2017-03-13 | English | Compare |
| v2 | 2017-03-13 | French | Compare |
| v3 | 2017-04-02 | English | Compare |
Showing 1 to 3 of 3